Growth Metrics

Exagen (XGN) Gross Profit (2018 - 2025)

Exagen's Gross Profit history spans 8 years, with the latest figure at $9.2 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 8.6% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $38.8 million, up 17.18%, while the annual FY2025 figure was $38.8 million, 17.18% up from the prior year.
  • Gross Profit reached $9.2 million in Q4 2025 per XGN's latest filing, down from $10.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $10.4 million in Q2 2025 to a low of $1.5 million in Q2 2022.
  • Average Gross Profit over 5 years is $7.5 million, with a median of $7.9 million recorded in 2021.
  • Peak YoY movement for Gross Profit: crashed 79.13% in 2022, then surged 443.26% in 2023.
  • A 5-year view of Gross Profit shows it stood at $7.8 million in 2021, then fell by 15.77% to $6.5 million in 2022, then increased by 24.77% to $8.1 million in 2023, then rose by 4.08% to $8.5 million in 2024, then rose by 8.6% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Gross Profit are $9.2 million (Q4 2025), $10.1 million (Q3 2025), and $10.4 million (Q2 2025).